Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Infectious diseases · Lancet Microbe · 2026-06-08
RCTn = 199
Bezabih et al. Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trialInfectious diseases · Lancet Microbe · 2026-06-08
RCTn = 176
Bezabih et al. Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trialInfectious diseases · Lancet Infect Dis · 2026-02-11
RCTn = 960
Degaga et al. Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial